36C24426Q0860_1.docx
DOCX document 31 KB Posted
- Attached to
- 6515--Dry Eye Treatment System
- Solicitation number
- 36C24426Q0860
About this file
This is a Presolicitation Notice for a Dry Eye Treatment System solicitation issued by the Department of Veterans Affairs (VA) through the Pittsburgh Network Contracting Office for the Coatesville VA Medical Center Optometry Department. The solicitation number is 36C24426Q0860, with a response date of August 14, 2026, at 6:00 AM Eastern Time. The Product Service Code is 6515 (Medical Equipment and Supplies), and the NAICS Code is 334510 (Electromedical and Electrotherapeutic Apparatus Manufacturing).
The Coatesville VA Medical Center seeks an FDA-approved monopolar dual frequency radiofrequency (RF) device with electronic dynamic muscle stimulation (DMS) capabilities to treat ocular surface and eyelid diseases, including dry eye syndrome, meibomian gland disease, blepharitis, and Acne Rosacea. The device must utilize dual frequency RF technology to reduce electrical arcing risk and ensure uniform heating of deeper eyelid tissues, be non-pigment dependent to treat patients of all skin tones, require no anesthesia or topical applications, and include electronic muscle stimulation for mechanical correction of eyelid function. The Lumenis BE OptiLift System is referenced as a comparable product for salient characteristics only, with no brand-name requirement intended. The contractor must provide delivery, assembly, installation, on-site staff training, and waste disposal during standard business hours (Monday-Friday, 7:30 AM to 4:30 PM, excluding federal holidays), with scheduling coordinated at least seven business days prior to shipment. The formal RFQ (36C24226Q0710) will be posted within ten days of this presolicitation notice, and the acquisition is subject to Free Trade Agreements.
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Presolicitation Notice Presolicitation Notice
| SUBJECT* |
| Dry Eye Treatment System |
GENERAL INFORMATION
| CONTRACTING OFFICE’S ZIP CODE* |
| 15215 |
| SOLICITATION NUMBER* |
| 36C24426Q0860 |
| RESPONSE DATE/TIME/ZONE |
| 08-14-2026 6:00AM EASTERN TIME, NEW YORK, USA |
| ARCHIVE |
| 10 DAYS AFTER THE RESPONSE DATE |
SET-ASIDE
| PRODUCT SERVICE CODE* |
| 6515 |
| NAICS CODE* |
| 334510 |
| PLACE OF PERFORMANCE |
| Department of Veterans Affairs |
Coatesville VA Medical Center
1400 Blackhorse Hill Rd
Coatesville PA
| POSTAL CODE |
| 19320 |
| COUNTRY |
| USA |
CONTACT INFORMATION
| CONTRACTING OFFICE ADDRESS |
| Department of Veterans Affairs |
Network Contracting Office 4 1010 Delafield Road Pittsburgh, PA 15215
POINT OF CONTACT*
Contract Specialist Jeff Mann jefferson.mann@va.gov 717-202-5456
ADDITIONAL INFORMATION
| AGENCY’S URL |
| https://www.va.gov |
| URL DESCRIPTION |
| Veterans Affairs |
| AGENCY CONTACT’S EMAIL ADDRESS |
| jefferson.mann@va.gov |
EMAIL DESCRIPTION
DESCRIPTION
In accordance with RFO FAR 5.101, this Presolicitation Notice is issued to inform potential vendors that a solicitation for the Treatment of Dry Eyes will be posted to the government point of entry within the next ten days.
All responsible sources may submit a quotation, in accordance with the Request for Quotes (RFQ) requirements, which will be considered by the agency.
Vendors are notified that “One or more of the items under this acquisition is subject to Free Trade Agreements.”
Please see RFQ 36C24226Q0710, once posted for further information and submission instructions.
STATEMENT OF NEED
Coatesville Veterans Affairs Medical Center (VAMC) Optometry Department Treatment Modality for Management of Ocular Surface and Eyelid Disease
DESCRIPTION:
The Optometry Department of Coatesville VA Medical Center (VAMC) requires a device specifically designed to address ocular surface and eyelid diseases, such as dry eye syndrome, meibomian gland disease, blepharitis, Acne Rosacea, and related skin conditions around the eyes. The required technology must utilize dual frequency monopolar Radio Frequency (RF) and electronic dynamic muscle stimulation (DMS) to deliver heat and muscle stimulation at varying tissue depths. This modality aims to increase blood circulation, enhance meibomian gland function, improve muscle tone, and boost blinking efficiency, thereby providing relief for patients with these conditions.
The device must employ monopolar RF technology, which is essential as it reduces the risk of electrical arcing and ensures rapid, uniform heating of deeper eyelid tissues.
Dual frequency RF technology is necessary because it does not cause skin depigmentation and is not contraindicated for any patient population. This feature allows for more aggressive management of dry eye in all veterans at Coatesville. Treatments with this technology enhance blood circulation, stimulate collagen production, and support meibomian gland function. Treatments enhance blood circulation, stimulate collagen production, and provide meibomian gland function.
Dynamic muscle stimulation is also required for mechanical, non-invasive correction of eyelid muscle tone to restore normal function. Abnormal eyelid function increases the risk of corneal surface irregularities, epithelial breakdown, and permanent vision loss. Dynamic muscle stimulation uses controlled electrical pulses to reactivate and restore resting muscle tone in the orbicularis oculi. These treatments improve blinking efficiency, stabilize the natural tear film, protect the cornea from progressive exposure damage, and reduce the need for daily home care.
SCOPE:
The contractor shall provide a new FDA approved Monopolar Dual Frequency RF with Electronic Dynamic Muscle Stimulation. The device must be able to treat patients of all skin tones for dry eye syndrome, meibomian gland disease, blepharitis, Acne Rosacea, and conditions affecting the skin around the eyes. All minimum salient characteristics must be met.
The Lumenis BE OptiLift System is a Brand Name Product provided for reference comparable salient characteristics only; no brand-name requirement is intended.
SALIENT CHARACTERISTICS
| • | FDA-approved specifically for ophthalmic and optometric use |
| • | Clinically validated for treatment of all scope diagnoses |
| • | Monopolar Application |
| • | Utilizes dual frequency technology |
| • | Utilizes electronic dynamic muscle stimulation |
| • | Multiple RF frequencies capable of tailoring depth and intensity of treatments to specific skin thickness and patient needs |
| • | Non-pigment dependent system |
| • | No required anesthesia, topical numbing creams, injections, or eye drops |
| • | Zero post-procedure downtime |
| • | Touch screen display |
| • | Rounded electrode contoured for eyes to maximize patient safety and comfort |
| • | Automatic treatment presets |
DELIVERY REQUIREMENTS:
Supplier shall perform all required assembly in accordance with the manufacturers’ instructions.
Supplier shall inspect to ensure that the system is clean, has no scratches and that the installation is complete and ready for patient use. The vender will provide on-site training to staff.
Vendor shall remove all trash, cartons, debris, and must provide and execute a recycling plan for cartons and cardboard disposal.
Vendor shall be responsible for delivery, assembly/installation, and training during normal business hours Monday-Friday 7:30 am to 4:30 pm, excluding any declared Federal Holidays.
Scheduling for delivery shall be coordinated at least 7 business days prior to shipment.
End of Document
| *=Required Field |
| Presolicitation Notice |
Presolicitation Notice
File details come from the government source that posted it. Updated .